Economic impact of oral corticosteroids in severe asthmatics: a simulation study in selected European countries
A. Bourdin (Montpellier, France), E. Bel (Amstersam, Netherlands), B. Dahlén (Stockholm, Sweden), R. Djukanovic (Southampton, United Kingdom), E. Heffler (Milano, Italy), P. Kuna (Lodz, Poland), R. Louis (Liege, Belgium), C. Porsbjerg (Copenhagen, Denmark), D. Ramos-Barbon (Barcelona, Spain), S. Škrgat (Ljubljana, Slovenia), G. Bruno (Pavia, Italy), S. Di Matteo (Milano, Italy), C. Martinotti (Milano, Italy), G. Colombo (Pavia, Italy), T. Paulsson (London, United Kingdom), B. Mascialino (Verona, Italy)
Source: International Congress 2022 – Asthma treatment: real-world studies and other diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Bourdin (Montpellier, France), E. Bel (Amstersam, Netherlands), B. Dahlén (Stockholm, Sweden), R. Djukanovic (Southampton, United Kingdom), E. Heffler (Milano, Italy), P. Kuna (Lodz, Poland), R. Louis (Liege, Belgium), C. Porsbjerg (Copenhagen, Denmark), D. Ramos-Barbon (Barcelona, Spain), S. Škrgat (Ljubljana, Slovenia), G. Bruno (Pavia, Italy), S. Di Matteo (Milano, Italy), C. Martinotti (Milano, Italy), G. Colombo (Pavia, Italy), T. Paulsson (London, United Kingdom), B. Mascialino (Verona, Italy). Economic impact of oral corticosteroids in severe asthmatics: a simulation study in selected European countries. 1338
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|